CDE vs. TGTX
CDE (Coeur Mining, Inc.) and TGTX (TG Therapeutics, Inc.) are both stocks. CDE operates in Gold (Basic Materials), while TGTX operates in Biotechnology (Healthcare). Over the past 10 years, CDE returned -0.45%/yr vs 24.71%/yr for TGTX. Their 0.14 correlation means their historical movements had little consistent relationship.
Performance
CDE vs. TGTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CDE achieves a -16.28% return, which is significantly lower than TGTX's 74.54% return. Over the past 10 years, CDE has underperformed TGTX with an annualized return of -0.45%, while TGTX has yielded a comparatively higher 24.71% annualized return.
CDE
- 1D
- -3.18%
- 1M
- -9.85%
- 6M
- -26.97%
- YTD
- -16.28%
- 1Y
- 71.77%
- 3Y*
- 71.68%
- 5Y*
- 14.64%
- 10Y*
- -0.45%
- ALL TIME*
- -7.51%
TGTX
- 1D
- -2.80%
- 1M
- -2.78%
- 6M
- 76.79%
- YTD
- 74.54%
- 1Y
- 46.56%
- 3Y*
- 70.54%
- 5Y*
- 8.26%
- 10Y*
- 24.71%
- ALL TIME*
- -7.87%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $522.01M | $427.77M | $535.96M | |
| $111.05M | $115.82M | $119.77M |
CDE vs. TGTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CDE Coeur Mining, Inc. | -16.28% | 211.71% | 75.46% | -2.98% | -33.33% | -51.30% | 28.09% | 80.76% | -40.40% | -17.49% |
TGTX TG Therapeutics, Inc. | 74.54% | -0.96% | 76.23% | 44.38% | -37.74% | -63.48% | 368.65% | 170.73% | -50.00% | 76.34% |
Correlation
The correlation between CDE and TGTX is 0.21, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.21 |
Correlation (3Y) Balances recent behavior with more history. | 0.14 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.20 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.17 |
Correlation (All Time) Calculated using the full available price history since May 3, 2010 | 0.14 |
Fundamentals
CDE:
$15.37B
TGTX:
$7.96B
CDE:
$1.84
TGTX:
$2.88
CDE:
8.09
TGTX:
18.04
CDE:
0.07
TGTX:
0.03
CDE:
2.52
TGTX:
11.90
CDE:
$2.57B
TGTX:
$700.35M
CDE:
$909.07M
TGTX:
$581.54M
CDE:
$1.23B
TGTX:
$156.88M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CDE vs. TGTX — Risk / Return Rank
CDE
TGTX
CDE vs. TGTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Coeur Mining, Inc. (CDE) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CDE | TGTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.01 | ||
| Sortino ratioReturn per unit of downside risk | -0.01 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.21 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.51 | 1.74 | -0.23 |
| Martin ratioReturn relative to average drawdown | 2.74 | 3.46 | -0.72 |
Loading charts...
Drawdowns
CDE vs. TGTX - Drawdown Comparison
The maximum CDE drawdown since its inception was -99.40%, roughly equal to the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for CDE and TGTX.
Loading charts...
Drawdown Indicators
| CDE | TGTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.40% | -99.52% | +0.12% |
Max Drawdown (1Y)Largest decline over 1 year | -47.79% | -26.85% | -20.94% |
Max Drawdown (3Y)Largest decline over 3 years | -47.79% | -42.06% | -5.73% |
Max Drawdown (5Y)Largest decline over 5 years | -72.69% | -89.47% | +16.78% |
Max Drawdown (10Y)Largest decline over 10 years | -87.42% | -93.19% | +5.77% |
Current DrawdownCurrent decline from peak | -94.83% | -77.71% | -17.12% |
Average DrawdownAverage peak-to-trough decline | -81.54% | -91.31% | +9.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.29% | 13.66% | +12.63% |
Volatility
CDE vs. TGTX - Volatility Comparison
Coeur Mining, Inc. (CDE) has a higher volatility of 18.30% compared to TG Therapeutics, Inc. (TGTX) at 12.23%. This indicates that CDE's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CDE | TGTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.30% | 12.23% | +6.07% |
Volatility (6M)Calculated over the trailing 6-month period | 55.15% | 33.96% | +21.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 73.29% | 47.22% | +26.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.77% | 87.68% | -18.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.82% | 86.71% | -17.89% |
Dividends
CDE vs. TGTX - Dividend Comparison
CDE's dividend yield for the trailing twelve months is around 0.13%, while TGTX has not paid dividends to shareholders.
| Position | TTM |
|---|---|
CDE Coeur Mining, Inc. | 0.13% |
TGTX TG Therapeutics, Inc. | 0.00% |
Financials
CDE vs. TGTX - Financials Comparison
This section allows you to compare key financial metrics between Coeur Mining, Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CDE vs. TGTX - Profitability Comparison
CDE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Coeur Mining, Inc. reported a gross profit of 0.00 and revenue of 856.19M. Therefore, the gross margin over that period was 0.0%.
TGTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.
CDE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Coeur Mining, Inc. reported an operating income of 349.17M and revenue of 856.19M, resulting in an operating margin of 40.8%.
TGTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.
CDE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Coeur Mining, Inc. reported a net income of 246.76M and revenue of 856.19M, resulting in a net margin of 28.8%.
TGTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.
Frequently Asked Questions
CDE and TGTX have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CDE has higher volatility (18.30%) compared to TGTX (12.23%). In terms of maximum drawdown, CDE dropped -99.40% vs TGTX's -99.52%.
TGTX currently has the higher Sharpe Ratio (0.99 vs 0.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CDE and TGTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer